Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Angiodroid is a medical technology company providing diagnostic and interventional devices and support services for use in operating rooms and clinical procedures. The company serves hospitals and medical professionals with innovative technologies and offers custom solutions.
2 investors
Anodyne is a clinical-stage biotech company developing transdermal delivery technology for multi-milligram doses and complex formulations of existing therapies and emerging large molecules, aimed at simplifying chronic care.
2 investors
Anto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.
2 investors
AorticLab develops FLOWer, an embolic protection device featuring a 60 µm mesh designed to prevent debris-related complications during transcatheter aortic valve implantation (TAVI) and other cardiovascular procedures. The device captures debris and reduces embolic events to improve safety and patient outcomes in cardiac interventions.
2 investors
APASOMICS develops Apasomes, a drug delivery system using hydroxyapatite nanospheres designed to deliver bone-targeting medications like bisphosphonates more effectively while reducing side effects, for patients with osteoporosis and other bone diseases.
2 investors
Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics targeting thromboinflammatory and cardiovascular diseases. The company's lead candidate, APAC, is a heparin proteoglycan mimetic currently in clinical trials.
2 investors
Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases. The company leverages scientific expertise and infrastructure to advance novel therapeutics through preclinical and clinical development.
2 investors
Applyo Jena manufactures freeze-dried (lyophilized) molecular biology reagent mixtures in bead form ("Applyo Beads") that are stable at room temperature and ready to use for applications such as PCR, RT-qPCR, and isothermal amplification. It provides development, contract manufacturing, packaging, and IVD development support to research laboratories, biopharmaceutical companies, and diagnostics manufacturers.
2 investors
APrevent is a medical device company developing solutions for voice and speech disorders, including the VOIS adjustable long-term vocal implant to treat glottic insufficiency and AiSpeak, a SaaS speech conversion platform for patients with dysarthria. Its products serve ENT physicians and patients with laryngeal and speech conditions.
2 investors
AptsciAptamer Science develops aptamer-based drug delivery and diagnostic platforms for precision medicine applications. The company specializes in cancer therapeutics using its proprietary ApDC (Aptamer-Drug Conjugate) technology, as well as early-stage lung cancer diagnostic kits and emerging programs in immunotherapy and metabolic disease.
2 investors
Aradigm develops financial and delivery infrastructure for cell and gene therapies, partnering with payers, providers, manufacturers, and patients to enable sustainable access to transformative treatments through a pass-through business model.
2 investors
Araris develops proprietary antibody-drug conjugate (ADC) linker technology that enables one-step attachment of payloads to native antibodies for targeted cancer therapy. The platform generates stable, homogenous ADCs for oncology applications without requiring antibody re-engineering.
2 investors
Arase Therapeutics develops first-in-class oncology therapeutics that target ADP-ribose Hydrolases, novel proteins in cancer stress pathways. The company focuses on developing new cancer treatments for patients with various cancer types.
2 investors
Aravax is a clinical-stage biotechnology company developing next-generation immunotherapies to treat food allergies. Founded on technology from Alfred Health and Monash University, it operates internationally with offices in Melbourne, Australia and Oxford, UK.
2 investors
ArcDia International develops and manufactures in vitro diagnostic solutions for acute infections such as COVID-19, influenza, RSV, and CDI, enabling rapid decentralized testing in hospitals, healthcare centers, and workplaces. The company also offers mariAST for antimicrobial susceptibility testing and mariCloud for real-time epidemiological surveillance.
2 investors
Arcomed develops patient-specific craniofacial and bone implants that are 3D-printed in PEEK material in a clean room, replicating the geometry of human bone. Some implants incorporate a gravity-driven, nonelectric drip mechanism to deliver customizable drug doses for up to 20 days after surgery.
2 investors
ArctX Medical is developing Chill-AP, an investigational medical device that completed a First in Human Study and is preparing a pivotal study for early 2026. The device is currently limited to investigational use under United States law.
2 investors
Arcuro Medical develops the SuperBall all-suture soft-tissue repair system for orthopedic surgeons performing meniscal and rotator cuff procedures. The platform provides controlled tensioning and fixation for soft-tissue repair.
2 investors
Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer. It serves clinicians and biopharma partners through its Aventa clinical testing brand and translational science collaborations, using routine FFPE tumor samples to guide diagnosis and therapy selection.
2 investors
Armatus Bio develops vectorized RNA interference therapeutics targeting genetic neurological and neuromuscular diseases.
2 investors
Aroa Biosurgery develops soft tissue repair and wound management products based on its AROA ECM extracellular matrix platform, including bioscaffolds for acute and chronic wounds, surgical reconstruction, and hernia repair. Its products, such as Endoform, Myriad Matrix, and Symphony, are used by surgeons and clinicians for soft tissue repair and reconstruction.
2 investors
Arthex Biotech develops an investigational anti-miR therapeutic targeting an upregulated miRNA for the treatment of myotonic dystrophy, aiming to address the root cause of the disease. Its lead program uses an oligonucleotide conjugated to a fatty acid to improve delivery to muscle tissue at low active doses.
2 investors
Artiria Medical develops guidewire and access systems for neurovascular procedures, featuring the SmartGUIDE device with a dynamic, controllable tip for navigating tortuous intracerebral anatomy. Its products are aimed at endovascular surgeons and interventionalists treating conditions such as hemorrhagic and ischemic stroke.
2 investors
Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages. It provides expertise and collaboration to support the development and manufacturing of these therapies.
2 investors